<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0001">
 <label>Table 1</label>
 <caption>
  <p>Herbal Formulations as Possible Therapeutics against COVID-19 Infection.</p>
 </caption>
 <alt-text id="alt0005">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top">
     <bold>S.No</bold>
    </th>
    <th valign="top">
     <bold>Herbal Plant Species</bold>
    </th>
    <th valign="top">
     <bold>Active Compounds</bold>
    </th>
    <th valign="top">
     <bold>Mechanism of Action</bold>
    </th>
    <th valign="top">
     <bold>Therapeutic Property</bold>
    </th>
    <th valign="top">
     <bold>References</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top">1.</td>
    <td valign="top">
     <italic>Cannabis sativa</italic>
    </td>
    <td valign="top">Cannabinoid cannabidiol</td>
    <td valign="top">Anti-inflammatory action by via modulation of gene expression of ACE2 enzyme, serine protease TMPRSS2, protein pre-requisite for SARS-CoV2 invasion into host cells.</td>
    <td valign="top">Adjunct therapy and utilised as mouthwash and throat gargle products clinically and home use owing to their potential to decrease viral entry via the oral mucosa.</td>
    <td valign="top">(
     <xref rid="bib0244" ref-type="bibr">Wang et al., 2020b</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">2.</td>
    <td valign="top">
     <italic>Glycyrrhiza glabra</italic>
    </td>
    <td valign="top">Glycyrrhizin, glycyrrhetic acid, liquiritin and isoliquiritin</td>
    <td valign="top">Counterbalance the activeness of COVID-19 and could be used as an antiviral drug.</td>
    <td valign="top">Formation of antiviral nano-membrane by licorice processed with PVA solution for potential application as wound dressing materials, musk, gloves and against skin infection by electrospinning.</td>
    <td valign="top">(
     <xref rid="bib0041" ref-type="bibr">Chowdhury et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">3.</td>
    <td valign="top">
     <italic>Citrus</italic> sp.
    </td>
    <td valign="top">Essential oils, pectins, naringin and hesperidin (flavonoids).</td>
    <td valign="top">Binds with high affinity to cellular receptors of SARS-CoV-2 that restrain the pro-inflammatory overreaction of the immune system.</td>
    <td valign="top">Prophylaxis and treatment of COVID-19.</td>
    <td valign="top">(
     <xref rid="bib0152" ref-type="bibr">Meneguzzo et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">4.</td>
    <td valign="top">
     <italic>Porphyridium</italic> sp.
    </td>
    <td valign="top">Sulfated polysaccharides (carrageenan)</td>
    <td valign="top">Potent inhibitors of coronaviruses that inhibit the binding or internalization of virus into the host cells.</td>
    <td valign="top">Biocompatible compounds can be used as a coating material on the sanitary items for COVID-19 prevention.</td>
    <td valign="top">(
     <xref rid="bib0161" ref-type="bibr">Nagle et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">5.</td>
    <td valign="top">
     <italic>Citrus</italic> sp.
    </td>
    <td valign="top">Hispidin, lepidine E,and folic acid</td>
    <td valign="top">Inhibition of 3CL hydrolase enzyme known for counteracting the host innate immune response and explain the main interactions in inhibitor-enzyme complex.</td>
    <td valign="top">Promising therapeutic principle for developing drug candidates as anti-CoViD-19 drug.</td>
    <td valign="top">(
     <xref rid="bib0203" ref-type="bibr">Serseg et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">6.</td>
    <td valign="top">
     <italic>Nilavembu Kudineer</italic>
    </td>
    <td valign="top">Benzene 123 Triol</td>
    <td valign="top">Immuno-modulatory activity against ACE2 enzyme receptor, that routes virus entry in the pathogenesis of Novel coronavirus.</td>
    <td valign="top">Potent anti-viral capacity for drug development.</td>
    <td valign="top">(
     <xref rid="bib0241" ref-type="bibr">Walter et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">7.</td>
    <td valign="top">
     <italic>Curcuma longa, Anogeissus acuminata,</italic> and 
     <italic>Phyllanthus myrtifolius</italic>
    </td>
    <td valign="top">Curcumin, Anolignan A, Phyllamyricin B</td>
    <td valign="top">May act as molecular blockers for the virus or cell surface receptors.</td>
    <td valign="top">Can be useful alternative potential drug.</td>
    <td valign="top">(
     <xref rid="bib0010" ref-type="bibr">Alabboud and Javadmanesh, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">8.</td>
    <td valign="top">
     <italic>Nigella sativa</italic>
    </td>
    <td valign="top">Nigelledine, α- Hederin</td>
    <td valign="top">Inhibitory action of proteases; CoVs (3CL
     <sup>pro</sup>/M
     <sup>pro</sup>) (PDB ID 
     <ext-link ext-link-type="uri" xlink:href="pdb:6LU7" id="interref0001" xmlns:xlink="http://www.w3.org/1999/xlink">6LU7</ext-link> and 
     <ext-link ext-link-type="uri" xlink:href="pdb:2GTB" id="interref0002" xmlns:xlink="http://www.w3.org/1999/xlink">2GTB</ext-link>) active sites.
    </td>
    <td valign="top">Best potential to act in COVID-19 treatment, testified medicinal use for preventive purpose.</td>
    <td valign="top">(
     <xref rid="bib0022" ref-type="bibr">Bouchentouf and Missoum, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">9.</td>
    <td valign="top">
     <italic>Camellia sinensis</italic>
    </td>
    <td valign="top">Polyphenols (Sanguiin, Theaflavin gallate, Theaflavin digallate, Kaempferol, Punicalagin and Protocatechuic acid)</td>
    <td valign="top">Target COVID-19 main protease (M
     <sup>pro</sup>), key enzyme of coronavirus involved in virus replication and transcription, and impedes viral growth inside the host.
    </td>
    <td valign="top">Dietary intake of black tea aids resistance to fight against COVID-19 virus in early stages of human infection.</td>
    <td valign="top">(
     <xref rid="bib0062" ref-type="bibr">Giri et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">10.</td>
    <td valign="top">
     <italic>Zingiber officinale</italic>
    </td>
    <td valign="top">6-gingerol</td>
    <td valign="top">Higher binding affinity at active sites of R7Y COVID-19, main protease essential for replication and reproduction of SARS Cov-2</td>
    <td valign="top">Possesses excellent drug likeliness parameters with zero violations.</td>
    <td valign="top">(
     <xref rid="bib0191" ref-type="bibr">Rathinavel et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">11.</td>
    <td valign="top">
     <italic>Citrus</italic> sp.
    </td>
    <td valign="top">Naringin, Naringenin, Hesperetin and Hesperidin</td>
    <td valign="top">Inhibited expression of pro-inflammatory cytokines (COX-2, iNOS, IL-1β and IL-6) in macrophage cell line, restrained cytokines via inhibiting HMGB1 expression in a mouse model and impeded binding affinity of ACE 2, receptor of the coronavirus.</td>
    <td valign="top">Contemplation of potential anti-coronavirus and anti-inflammatory activity of flavonoids, derived phytochemicals are promising in the use of prevention and treatment of 2019-nCoV infection.</td>
    <td valign="top">(
     <xref rid="bib0035" ref-type="bibr">Cheng et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">12.</td>
    <td valign="top">
     <italic>Lawsonia inermis</italic>
    </td>
    <td valign="top">Fraxetin 1(3H)-isobenzofuranone</td>
    <td valign="top">Phytochemical, cytotoxicity and anti-inflammatory actions confirmed in fractions of extract as observed as a potent constituents.</td>
    <td valign="top">Cytotoxic compounds, warrant research to fabricate suitable formulations comprising these constituents.</td>
    <td valign="top">(
     <xref rid="bib0139" ref-type="bibr">Manuja et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">13.</td>
    <td valign="top">
     <italic>Allium sativum, Curcuma longa, Capsicum, Mentha pulegium, Stachysschtschegleevi, Astraglusgossypinus</italic>
    </td>
    <td valign="top">Diallyl Disulfide, Curcumin, Capsaicin, Limonene, Thymol, Verbascoside, Glucouronic acid</td>
    <td valign="top">Restrained viral protease enzyme by inhibiting amino acid synthesis.</td>
    <td valign="top">Compounds investigated especially, Curcumin could be strongest achiever against COVID-19.</td>
    <td valign="top">(
     <xref rid="bib0157" ref-type="bibr">Mohammadi and Shaghaghi, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">14.</td>
    <td valign="top">
     <italic>Ocimum sanctum, Curcuma longa, Tinospora cordiofolia, Piper nigrum.Zingiber officinale, Syzygium aromaticum, Elettaria cardamomum, Citrus Limon, Withania somnifera</italic>
    </td>
    <td valign="top">Oleanolic acid, Ursolic acid, Curcumin, Rosmarinic acid, Eugenol, Magnoflorine, Berberine, Piperine, Piperamide, Piperamine 6-gingerol, Quercetin, Hesperetin, Protocatechualdehyde, Caryophyllene,Withaferin</td>
    <td valign="top">Higher binding affinity with viral and host macromolecular targets and other human pro-inflammatory mediators, SARS-CoV-2 main proteases, spike, human ACE2 and furin proteins.</td>
    <td valign="top">Regularly consumped in the form of ayurvedic Kadha to boost immunity and dwindle chances of COVID-19 Infection.</td>
    <td valign="top">(
     <xref rid="bib0148" ref-type="bibr">Maurya and Sharma, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">15.</td>
    <td valign="top">
     <italic>Cnidoscolus aconitifolius</italic>
    </td>
    <td valign="top">Phenols, Flavonoids, Flavonones and Hydroflavonoles</td>
    <td valign="top">Highest ACE2 enzyme inhibition, anti-inflammatory activity, modulated α-gene expression for TNF- production in macrophages.</td>
    <td valign="top">Bioactive compounds could be used for drug formulations.</td>
    <td valign="top">(
     <xref rid="bib0150" ref-type="bibr">Medina and Segura-Campos, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">16.</td>
    <td valign="top">
     <italic>Scutellaria baicalensis</italic>
    </td>
    <td valign="top">Baicalein</td>
    <td valign="top">Anti-SARS-CoV-2 activity via suppressing SARS-CoV-2 3CL
     <sup>pro</sup> and replication.
    </td>
    <td valign="top">Effective compounds as anti-SARS-CoV-2 inhibitors.</td>
    <td valign="top">(
     <xref rid="bib0126" ref-type="bibr">Liu et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">17.</td>
    <td valign="top">
     <italic>Ginkgo biloba</italic>
    </td>
    <td valign="top">Ginkgolic acids</td>
    <td valign="top">Impeded DNA and protein synthesis by binding towards host cell receptors to activate cell-signaling pathways for arresting cell cycle as an inhibitory action.</td>
    <td valign="top">Sturdy effect of GA on viral infection, to be potentially used to treat coronavirus infections.</td>
    <td valign="top">(
     <xref rid="bib0021" ref-type="bibr">Borenstein et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">18.</td>
    <td valign="top">
     <italic>Allium sativum</italic>
    </td>
    <td valign="top">Essential oil, Allyl disulfide, Allyl trisulfide</td>
    <td valign="top">Acted as ACE2 receptor inhibitor for resistance against Coronavirus along with activity against main proteases of SARS-CoV-2.</td>
    <td valign="top">Essential oil as valuable natural antivirus source, contributing towards preventing the invasion of coronavirus into the human body.</td>
    <td valign="top">(
     <xref rid="bib0227" ref-type="bibr">Thuy et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">19.</td>
    <td valign="top">
     <italic>Curcuma sp., Citrus sp., Alpinia galanga</italic> and 
     <italic>Caesalpinia sappan</italic>
    </td>
    <td valign="top">Curcumin, Hesperidin, Galangin and Brazilin</td>
    <td valign="top">Anti-SARS-CoV-2 through its binding to 3-protein receptors with good affinity performing an inhibitory potential against viral infection and replication.</td>
    <td valign="top">Consumed in daily life as prophylaxis of COVID-19.</td>
    <td valign="top">(
     <xref rid="bib0233" ref-type="bibr">Utomo and Meiyanto 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">20.</td>
    <td valign="top">
     <italic>Alpinia officinarum, Zingiber officinale</italic>
    </td>
    <td valign="top">Curcumin and Gingerol</td>
    <td valign="top">SARS-CoV-2 papain-like protease (PLpro) inhibitors.</td>
    <td valign="top">Potent drugs to treat corona infections.</td>
    <td valign="top">(
     <xref rid="bib0067" ref-type="bibr">Goswami et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">21.</td>
    <td valign="top">
     <italic>Myrica cerifera, Psorothamnus Arborescens, Phaseolus Vulgaris, Camellia sinensis, Hyptis atrorubens Poit, Amaranthus tricolor, Glycyrrhiza uralensis</italic>
    </td>
    <td valign="top">Myricitrin, Methyl Rosmarinate, 5,7,3′,4′-Tetrahydroxy-2′-(3,3- dimethylallyl) isoflavone, 3,5,7,3′,4′,5′-hexahydroxy flavanone-3-Obeta-D-glucopyranoside, Myricetin 3 Obeta-D-glucopyranoside, Amaranthin, Licoleafol</td>
    <td valign="top">Inhibited SARS-CoV-2 3CL pro-activity and virus replication.</td>
    <td valign="top">Probable inhibitors into clinical drugs for exploring and developing novel natural anti-COVID-19 therapeutic agents in the future.</td>
    <td valign="top">(
     <xref rid="bib0232" ref-type="bibr">ul Qamar et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">22.</td>
    <td valign="top">
     <italic>Nyctanthes arbortristis, Glycyrrhiza glabra, Aloe vera Curcuma longa, Azadirachta indica, Withania sominifera, Cannabis sativa, Ocimum sanctum, Allium cepa,Zingiber officinale</italic>
    </td>
    <td valign="top">Nictoflorin Astragalin, Lupeol Berberine,Sitosterol, Aloenin, Aloesin, Curcumin, Nimbin, Withanolide, Withaferin A, Shogaol, Quercetin, Ursolic acid, Apigenin, Cannabidiol,Piperine, Gingerol</td>
    <td valign="top">Potential inhibitors of COVID-19 proteases.</td>
    <td valign="top">Promising development of herbal medicines.</td>
    <td valign="top">(
     <xref rid="bib0216" ref-type="bibr">Srivastava et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">23.</td>
    <td valign="top">
     <italic>Curcuma longa, Zingiber officinale</italic>
    </td>
    <td valign="top">Curcumin, Nelfinavir, Lopinavir, Luteolin-7-glucoside, Demethoxycurcumin, Apigenin-7-glucoside, Oleuropein, Catechin, and epicatechin-gallate</td>
    <td valign="top">Best potential to act as COVID-19 M
     <sup>pro</sup> inhibitors.
    </td>
    <td valign="top">Treatment and prophylaxis</td>
    <td valign="top">(
     <xref rid="bib0104" ref-type="bibr">Khaerunnisa et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">24.</td>
    <td valign="top">
     <italic>Ginkgo biloba</italic>
    </td>
    <td valign="top">Ginkgolide A, Terpenoids</td>
    <td valign="top">Stronger bond and high affinity with proteases.</td>
    <td valign="top">Compounds may be considered as effective COVID_19 antiproteases drugs.</td>
    <td valign="top">(
     <xref rid="bib0204" ref-type="bibr">Shaghaghi, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">25.</td>
    <td valign="top">
     <italic>Camellia sinensis</italic>
    </td>
    <td valign="top">Epigallocatechin gallate</td>
    <td valign="top">Targets include main proteases covid-19, post fusion core of 2019-nCoV S2 subunit, prefusion spike glycoproteins and NSP15 endoribonuclease from SARS CoV-2.</td>
    <td valign="top">Future drug candidate for COVID-19.</td>
    <td valign="top">(
     <xref rid="bib0105" ref-type="bibr">Khan et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">26.</td>
    <td valign="top">
     <italic>Silybum marianum, Withania somnifera, Tinospora cordiofolia</italic> and 
     <italic>Aloe barbadensis</italic>
    </td>
    <td valign="top">Silybin, Withaferin A</td>
    <td valign="top">SARSCoV-2 inhibitors namely, Spike (S) glycoproteins, main protease (M
     <sup>pro</sup>) and RNA-dependent RNA-polymerases (RdRp)
    </td>
    <td valign="top">Could be useful traditional medicine for treatment for COVID-19 infection.</td>
    <td valign="top">(Pandit, 2020)</td>
   </tr>
   <tr>
    <td valign="top">27.</td>
    <td valign="top">
     <italic>Citrus, Curcuma longa</italic>
    </td>
    <td valign="top">Hesperidin, Rutin, Diosmin, Apiin, Diacetyl curcumin</td>
    <td valign="top">Inhibitory action against SARS-CoV-2 main protease (M
     <sup>pro</sup>).
    </td>
    <td valign="top">Medicinal potential to cure COVID-19.</td>
    <td valign="top">(
     <xref rid="bib0004" ref-type="bibr">Adem et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">28.</td>
    <td valign="top">
     <italic>Exocarpium Citri grandis</italic>
    </td>
    <td valign="top">Flavonoids and Naringin</td>
    <td valign="top">Antitussive, expectorant, improved lung function, pulmonary fibrosis, and antiviral immune response.</td>
    <td valign="top">Reference for its clinical application in the prevention and treatment of multiple respiratory diseases, including coronavirus disease.</td>
    <td valign="top">(
     <xref rid="bib0218" ref-type="bibr">Su et al., 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">29.</td>
    <td valign="top">
     <italic>Eucalyptus</italic> sp.
    </td>
    <td valign="top">Jensenone</td>
    <td valign="top">COVID-19 M
     <sup>pro</sup> inhibitor
    </td>
    <td valign="top">Eucalyptus oil could be use for prevention and cure.</td>
    <td valign="top">(
     <xref rid="bib0206" ref-type="bibr">Sharma and Kaur, 2020</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">30.</td>
    <td valign="top">
     <italic>Betula pubescens</italic>
    </td>
    <td valign="top">Herbacetin, Isobavachalcone, Quercetin, 3‐β‐d‐glucoside, Helichrysetin and Betulinic acid</td>
    <td valign="top">Inhibitory compounds against MERS‐CoV 3C‐like proteases (3CLpro).</td>
    <td valign="top">Flavonoids with these characteristics can be used as templates to develop potent MERS‐CoV 3CLpro inhibitors.</td>
    <td valign="top">(
     <xref rid="bib0095" ref-type="bibr">Jo et al., 2019</xref>)
    </td>
   </tr>
   <tr>
    <td valign="top">31.</td>
    <td valign="top">
     <italic>Zingiber Officinale, Piper longum, Syzygium aromaticum, Tragia involucrata, Hygrophila auriculata, Terminalia chebula, Justicia adhatoda,,Saussurea costus,Tinospora sinensis</italic> and 
     <italic>Premna herbace a</italic>
    </td>
    <td valign="top">6-Shogaol, 6-Gingerol, Beta Sitosterol, Piperidine, Apigenin, Piperine, Quercetin, Chlorogenic Acid, Andrographolide, Bharangin, Carvacrol, Cissamine,Costunolide, Cucurbitacin B, Gallic acid, Linoleic acid, Pellitorine, Rutin, Santalic acid, Cynaropicrin, Eugenol, Thymol and Vitexin)</td>
    <td valign="top">Binding potential with active residues of ACE2 that mediate host viral interface.</td>
    <td valign="top">Future systematic investigation could validate the efficacy prior to the recommendation.</td>
    <td valign="top">(
     <xref rid="bib0049" ref-type="bibr">Dhanasekaran and Pradeep, 2020</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
